<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
NEW YORK, Aug. 6, 2021 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intersect ENT, Inc. (“Intersect” or the “Company”) (NASDAQ: XENT) in connection with the proposed acquisition of the Company by Medtronic plc (“Medtronic”) (NYSE:MDT). Under the terms of the merger agreement, the Company’s shareholders will receive $28.25 per share in cash for each share of Intersect common stock that they hold.
...read full article on PRNewsWire
